Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24609685 | 0.94 | SERPINE1 (0.48) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609579 | 0.92 | SERPINE1 (0.54) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609775 | 0.91 | MEN1 (0.52) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609895 | 0.88 | SERPINE1 (0.48) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609678 | 0.87 | SERPINE1 (0.48) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609587 | 0.85 | MEN1 (0.47) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24610035 | 0.83 | MEN1 (0.53) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL22912465 | 0.80 | SERPINE1 (0.46) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL24609799 | 0.79 | MEN1 (0.47) | SERPINE1KDM4ENPSR1RXFP1MEN1 | |
| SCHEMBL8980359 | 0.79 | NPC1 (0.69) | MEN1KMT2AADORA3ADORA1PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213098-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213098-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | SERPINE1 4369/4885KDM4E 2576/4885NPSR1 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.